Cell lines

Horizon Discovery enters crowded CHO cell line market

Horizon Discovery enters crowded CHO cell line market

By Zachary Brennan

Horizon Discovery Group announced Monday that its bioproduction division has shipped its first commercially available engineered CHO (Chinese Hamster Ovary) cell line for use in manufacturing of antibodies. 

Green chemistry yet to attract drug industry

Pre CPhI Special

How green was my Valium? Not very, despite industry claims

By Gareth Macdonald

Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to believe claims drug industry 'demand' will create a $100bn market for environmentally-friendly production methods by 2020.

GSK is preparing 10,000 doses as a Phase I trial begins.

GSK begins manufacturing 10,000 Ebola vaccine doses for WHO

By Zachary Brennan

As more than half a dozen companies are now vying to help treat and vaccinate Ebola victims in West Africa, where nearly 3,000 people have died from the illness, GlaxoSmithKline is taking the lead in getting product manufactured.

Bright eyes was OK at best

infographic feature

Better together? biosimilars sector says aye

By Gareth Macdonald and Dan Stanton

Partnerships are a mixed bag.For every oppressed group yearning to throw off the yoke of their imperialist overlords, there is an Art Garfunkel or Daryl Hall solo album to illustrate the positive impact collaboration can have.

Pfenex set for new direction as it uses its expression technology to develop its biosimilar pipeline

Pfenex focuses on biosimilars post IPO

By Dan Stanton

Revenues from protein production will decline as Pfenex shifts attention to its biosimilar pipeline, the newly public company says.